OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 6.17
+0.15 (2.49%)
Aug 13, 2026, 5:29 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 86.68 million as of August 13, 2026. Its market cap has increased by 6.59% in one year.
Market Cap
86.68M
Enterprise Value
93.24M
Revenue
71.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
6.17
ChartMarket Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 86.68M, a decrease of -2.63%. That is a compound annual growth rate of -0.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 86.68M | 1.38% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 140.38M |
| Active Biotech AB | 138.39M |
| NextCell Pharma AB | 130.18M |
| Annexin Pharmaceuticals AB | 86.47M |
| Ascelia Pharma AB | 76.12M |
| Spago Nanomedical AB | 76.08M |
| AcouSort AB | 73.02M |
| Pila Pharma AB | 60.99M |